| Dr Luke Robert Perrin, MD | |
|
210 4th Ave, Grinnell, IA 50112-1898 | |
| (641) 236-2378 | |
| Not Available |
| Full Name | Dr Luke Robert Perrin |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 22 Years |
| Location | 210 4th Ave, Grinnell, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407834740 | NPI | - | NPPES |
| I20940022 | Other | IA | MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 35231 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercyone Newton Medical Center | Newton, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Newton Clinic Pc | 6608768676 | 22 |
News Archive
Many studies support the assertion that moderate drinking is beneficial when it comes to cardiovascular health, and for the first time scientists have discovered that a well-known molecule, called Notch, may be behind alcohol's protective effects. Down the road, this finding could help scientists create a new treatment for heart disease that mimics the beneficial influence of modest alcohol consumption.
A mechanism that cells use to group together and move around the body - called 'chase and run' - has been described for the first time by scientists at UCL.
The Children's Hospital of Philadelphia (CHOP) and BGI-Shenzhen today announced a formal agreement to collaborate on research into next-generation sequencing and analysis of pediatric brain tumors, in support of the Childhood Brain Tumor Tissue Consortium (CBTTC).
The second of two studies on latrepirdine, recently published in Molecular Psychiatry, demonstrates new potential for the compound in the treatment of Alzheimer's disease, Parkinson's disease, sleep disorders, and other neurodegenerative conditions. An international team led by Mount Sinai School of Medicine scientists found that latrepiridine, known commercially as Dimebon, reduced the level of at least two neurodegeneration-related proteins in mice.
The current COVID-19 pandemic began as a zoonosis in China, at the end of 2019, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel betacoronavirus with significant similarity to an earlier virus of the same family.
› Verified 1 days ago
| Entity Name | Newton Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730115213 PECOS PAC ID: 6608768676 Enrollment ID: O20040325000962 |
News Archive
Many studies support the assertion that moderate drinking is beneficial when it comes to cardiovascular health, and for the first time scientists have discovered that a well-known molecule, called Notch, may be behind alcohol's protective effects. Down the road, this finding could help scientists create a new treatment for heart disease that mimics the beneficial influence of modest alcohol consumption.
A mechanism that cells use to group together and move around the body - called 'chase and run' - has been described for the first time by scientists at UCL.
The Children's Hospital of Philadelphia (CHOP) and BGI-Shenzhen today announced a formal agreement to collaborate on research into next-generation sequencing and analysis of pediatric brain tumors, in support of the Childhood Brain Tumor Tissue Consortium (CBTTC).
The second of two studies on latrepirdine, recently published in Molecular Psychiatry, demonstrates new potential for the compound in the treatment of Alzheimer's disease, Parkinson's disease, sleep disorders, and other neurodegenerative conditions. An international team led by Mount Sinai School of Medicine scientists found that latrepiridine, known commercially as Dimebon, reduced the level of at least two neurodegeneration-related proteins in mice.
The current COVID-19 pandemic began as a zoonosis in China, at the end of 2019, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel betacoronavirus with significant similarity to an earlier virus of the same family.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Luke Robert Perrin, MD 210 4th Ave, Grinnell, IA 50112-1898 Ph: (641) 236-2378 | Dr Luke Robert Perrin, MD 210 4th Ave, Grinnell, IA 50112-1898 Ph: (641) 236-2378 |
News Archive
Many studies support the assertion that moderate drinking is beneficial when it comes to cardiovascular health, and for the first time scientists have discovered that a well-known molecule, called Notch, may be behind alcohol's protective effects. Down the road, this finding could help scientists create a new treatment for heart disease that mimics the beneficial influence of modest alcohol consumption.
A mechanism that cells use to group together and move around the body - called 'chase and run' - has been described for the first time by scientists at UCL.
The Children's Hospital of Philadelphia (CHOP) and BGI-Shenzhen today announced a formal agreement to collaborate on research into next-generation sequencing and analysis of pediatric brain tumors, in support of the Childhood Brain Tumor Tissue Consortium (CBTTC).
The second of two studies on latrepirdine, recently published in Molecular Psychiatry, demonstrates new potential for the compound in the treatment of Alzheimer's disease, Parkinson's disease, sleep disorders, and other neurodegenerative conditions. An international team led by Mount Sinai School of Medicine scientists found that latrepiridine, known commercially as Dimebon, reduced the level of at least two neurodegeneration-related proteins in mice.
The current COVID-19 pandemic began as a zoonosis in China, at the end of 2019, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel betacoronavirus with significant similarity to an earlier virus of the same family.
› Verified 1 days ago
Michelle S Rebelsky, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 210 4th Ave, Grinnell, IA 50112 Phone: 641-236-2525 Fax: 641-236-2935 | |
Dr. Roy A Doorenbos, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 210 4th Ave, Grinnell, IA 50112 Phone: 641-236-2500 Fax: 641-236-2539 | |
Dr. Ryan Dahlby Albright, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 224 3rd Ave, Grinnell, IA 50112 Phone: 641-236-6740 Fax: 641-236-0013 | |
Dr. James R Paulson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 217 4th Ave W, Grinnell, IA 50112 Phone: 641-236-7524 Fax: 641-236-7944 | |
Dr. Patrick J Cogley, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 210 4th Ave, Grinnell, IA 50112 Phone: 641-236-2500 Fax: 641-236-2539 | |
April L. Forsyth, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 202 4th Ave Ste 300, Grinnell, IA 50112 Phone: 641-236-2323 |